Definition:Treaty pricing
💰 Treaty pricing is the process by which reinsurers determine the premium or economic terms for a reinsurance treaty — a standing agreement under which a ceding company transfers a defined class or portfolio of risks to one or more reinsurers over a specified period. Unlike facultative reinsurance, where each risk is individually evaluated and priced, treaty pricing must account for the aggregate characteristics of an entire book of business, making it a blend of actuarial science, market dynamics, and relationship-driven negotiation. The pricing outcome directly shapes the cedent's net retention, ceding commissions, and ultimately its profitability.
📊 Reinsurers build treaty prices using a combination of experience rating — analyzing the cedent's historical loss ratios, development patterns, and large loss activity — and exposure rating, which models expected losses based on the portfolio's composition independent of past results. For catastrophe treaties, catastrophe models from vendors like RMS, AIR, and Verisk play a central role, generating probable maximum loss estimates and exceedance probability curves that anchor the pricing discussion. Negotiations typically occur through reinsurance brokers who prepare detailed submissions and manage the placement across a panel of reinsurers, each of whom may quote slightly different terms based on their own risk appetite, capital position, and portfolio strategy.
📈 Getting treaty pricing right has far-reaching consequences for both sides of the transaction. For the cedent, overpaying erodes underwriting margins, while underpaying — or accepting inadequate coverage terms — leaves dangerous exposure on the balance sheet during adverse loss years. For reinsurers, mispricing a treaty can impair an entire book's performance for the duration of the contract period, sometimes multiple years. Market conditions play an outsized role: after major catastrophe events or periods of sustained underwriting losses, treaty pricing hardens significantly as capacity tightens, whereas prolonged benign loss periods tend to drive competitive softening. The rise of alternative capital from ILS markets has added another pricing pressure, giving cedents additional leverage during renewals.
Related concepts